The Latest Liquidations: February 15, 2023

Latest SPAC Liquidations: Ibere Pharmaceuticals, New Vista, Kadem Sustainable Impact Corp.

Ibere Pharmaceuticals (IBER) to Liquidate on March 2

Ibere Pharmaceuticals (NYSE:IBER) today announced that it will redeem all of its outstanding ordinary shares that were included in the units issued in its initial public offering, effective as of the close of business on March 2, 2023.

The per-share redemption price for the Public Shares will be approximately $10.17.

The Public Shares will cease trading as of the close of business on March 1, 2023. As of the close of business on March 2, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

New Vista Acquisition Corp. (NVSA) to Liquidate on February 19

New Vista Acquisition Corp. (NASDAQ: NVSA) today announced that it has cancelled the extraordinary general meeting that was previously scheduled for 10:00 a.m. on February 15. The company will not complete an initial business combination by February 19.

Therefore, following February 19, the company will proceed to redeem all of the Class A ordinary shares and will liquidate and dissolve.

The redemption of the Public Shares is expected to be completed by March 6, 2023.

Kadem Sustainable Impact Corp. (KSI) to Liquidate on March 19

Kadem Sustainable Impact Corporation (NASDAQ: KSI) today announced that it will redeem all of its outstanding shares of Class A common stock, effective as of the close of business on March 19.

The per-share redemption price for the public shares will be approximately $10.05.

The company anticipates that the public shares will cease trading as of the open of business on March 17, 2023 in order to allow time for the settlement of trades. As of the close of business on March 19, 2023, the public shares will be deemed cancelled and will represent only the right to receive the Redemption Amount.